BioEclipse Therapeutics, Inc Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
BioEclipse Therapeutics, Inc is a clinical-stage biotechnology company focused on oncology. It is developing a novel class of immune-based therapies designed to target solid tumors with precision for patients whose cancers have proven resistant or recurred. The approach seeks to engage both innate and adaptive immune responses to overcome challenges that have limited the effectiveness of immunotherapies in solid cancers. Based in Mountain View, California, the company operates within the biotechnology research sector and targets the clinical community and patients seeking new options for refractory solid tumors. It has pursued external collaborations to advance its lead program, including a partnership that supported an IND filing for CRX100.